Daoqi Wang

ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer

B. Broom, G. Peng, T. Thompson, 2021, Clinical Cancer Research.

PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer

B. Broom, P. Troncoso, C. Hudgens, 2021, Molecular Cancer Therapeutics.

ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer

B. Broom, G. Peng, T. Thompson, 2021, Clinical Cancer Research.

ATR inhibitor–induced CDK1-SPOP axis destabilizes PD-L1 and enhances cytotoxicity in prostate cancer

B. Broom, G. Peng, T. Thompson, 2021 .